Company Filing History:
3 out of 3 
2 out of 2 
1 out of 3,446 
Years Active: 1999-2011
Title: Julianna Lisziewicz: Pioneer in Genetic Delivery Systems
Introduction
Julianna Lisziewicz is an accomplished inventor based in Bethesda, MD, known for her groundbreaking work in the field of genetic delivery systems. With a total of 8 patents to her name, she has significantly contributed to advancements in gene therapy and immunization techniques.
Latest Patents
Among her latest inventions is the "Method of delivering genes into antigen presenting cells of the skin," which describes a molecular delivery complex designed to target antigen-presenting cells. This system utilizes a non-viral gene delivery approach, facilitating the entry of foreign genetic material into the targeted cells through a specific receptor. This complex not only aids in overcoming the degradation mechanisms but also ensures the functional uptake and gene expression of the foreign materials. Another notable patent is the "DNA composition and uses thereof," which presents a plasmid DNA encoding one or more antigenic genes, showing enhanced safety and efficiency in protein expression.
Career Highlights
Julianna has had a remarkable career, having worked with the Research Institute for Genetic and Human Therapy (r.i.g.h.t.) and Genetic Immunity, LLC. Her work has focused on transforming complex genetic information into practical applications that could revolutionize medical treatments and vaccination methods.
Collaborations
Throughout her career, Julianna has collaborated with distinguished professionals in her field, including Franco Lori and Jianqing Xu. These collaborations have played a crucial role in expanding the impact of her research and her inventions.
Conclusion
Julianna Lisziewicz continues to be an influential figure in the field of genetic research and therapy, consistently pushing the boundaries of how genetic information can be effectively delivered and utilized. Her contributions, reinforced by her patents and collaborations, mark her as a pioneer in innovative approaches to genetic immunization and treatment.